Accès ouvert
2026
conference-paper
OpenAlex
Roch Christian Johnson, Emma Sáez-López, Esaï Sèdjro Anagonou, Perrin Catraye et autres
Introduction: For Buruli Ulcer (BU), the World Health Organization (WHO) recommended the administration of rifampicin (R) and clarithromycin (C) for 8 weeks (RC8). Preclinical studies have demonstrated that the combination of amoxicillin/clavulanate (A) and RC is highly effective in vitro against Mycobacterium …
Bénin, Sénégal, fr, es, Tunisie, de, Togo, Ghana
(code pays fourni par la source)
Accès ouvert
2023
article
OpenAlex
Faraj Fajloun, Line Ganlonon, Ronald Sètondji Gnimavo, Espoir Sodjinou et autres
Here, we describe the first 10 years of activity at a field laboratory established at the Buruli ulcer treatment center (CDTLUB) in Pobè, Benin, a country in which Mycobacterium ulcerans is endemic. Between 2012 and 2022, the laboratory analyzed 3,018 samples from …
fr, lb, Bénin
(code pays fourni par la source)
Accès ouvert
2022
article
OpenAlex
Roch Christian Johnson, Emma Sáez-López, Sèdjro Gimatal Esaï Anagonou, Godwin Gérard Kpoton et autres
BACKGROUND: Buruli ulcer (BU) is a neglected tropical disease caused by Mycobacterium ulcerans that affects skin, soft tissues, and bones, causing long-term morbidity, stigma, and disability. The recommended treatment for BU requires 8 weeks of daily rifampicin and clarithromycin together with wound …
Bénin, fr, es, gb, it
(code pays fourni par la source)